Am­i­cus touts lat­est set of gene ther­a­py da­ta; No­vo Nordisk ex­pands dis­cov­ery deal for di­a­betes

→ The ex­ecs at Am­i­cus Ther­a­peu­tics $FOLD spared no ef­fort in tout­ing an ear­ly set of da­ta for their gene ther­a­py pro­gram to treat …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.